Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8837-8842

  Delviks, Krista A ^a   Pathak, Vinay K ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEOMYCIN; RNA DIRECTED DNA POLYMERASE; VIRUS VECTOR;

ARTICLE; DRUG RESISTANCE; GENE CASSETTE; GENE DELETION; GENE EXPRESSION; GENE THERAPY; IMMUNE RESPONSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0032845116     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8837-8842.1999     Document Type: Article

References (37)

1. Apperley, J. F., B. D. Luskey, and D. A. Williams. 1991. Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: effect of selectable marker sequences on long-term expression. Blood 78:310-317.
2. Artelt, P., R. Grannemann, C. Stocking, J. Friel, J. Bartsch, and H. Hauser. 1991. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 99:249-254.
3. Bowman, R. R., W. S. Hu, and V. K. Pathak. 1998. Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J. Virol. 72:5198-5206.
4. Bowtell, D. D. L., S. Cory, G. R. Johnson, and T. J. Gonda. 1988. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J. Virol. 62:2464-2473.
5. Byun, J., J. M. Kim, P. D. Robbins, and S. Kim. 1998. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site. Gene Ther. 5:1441-1444.
6. Calos, M. P., J. S. Lebkowski, and M. R. Botchan. 1983. High mutation frequency in DNA transfected into mammalian cells. Proc. Natl. Acad. Sci. USA 80:3015-3019.
7. Coffin, J. M. F. 1996. Retroviridae: the viruses and their replication. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa
8. Czernilofsky, A. P., A. D. Levinson, H. E. Varmus, J. M. Bishop, E. Tischer, and H. M. Goodman. 1980. Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature 287:198-203.
9. - vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J. Virol. 71:6218-6224.
10. Delviks, K. A., and V. K. Pathak. 1999. Effect of distance between homologous sequences and 3′ homology on the frequency of retroviral reverse transcriptase template switching. J. Virol. 73:7923-7932.
11. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:449-467.
12. Emerman, M., and H. M. Temin. 1986. Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 6:792-800.
13. Fernex, C., P. Dubreuil, P. Mannoni, and C. Bagnis. 1997. Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells. J. Virol. 71:7533-7540.
14. Gritz, L., and J. Davies. 1983. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25:179-188.
15. Hu, W. S., E. H. Bowman, K. A. Delviks, and V. K. Pathak. 1997. Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J. Virol. 71:6028-6036.
16. Hu, W. S., and H. M. Temin. 1990. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. USA 87:1556-1560.
17. Hughes, S., and E. Kosik. 1984. Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology 136:89-99.
18. Jang, S. K., M. V. Davies, R. J. Kaufman, and E. Wimmer. 1989. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63:1651-1660.
19. Jang, S. K., H. G. Krausslich, M. J. Nicklin, G. M. Duke, A. C. Palmenberg, and E. Wimmer. 1988. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:2636-2643.
20. Jorgensen, R. A, S. J. Rothstein, and W. S. Reznikoff. 1979. A restriction enzyme cleavage map of Tr5 and location of a region encoding neomycin resistance. Mol. Gen. Genet. 177:65-72.
21. - vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69:6839-6846.
22. Jung, D., E. Jaeger, S. Caveux, T. Blankenstein, C. Hilmes, J. Karbach, U. Moebius, A. Knuth, C. Huber, and B. Seliger. 1998. Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes. Hum. Gene Ther. 9:53-62.
23. Kent, R. B., J. R. Emanuel, Y. Ben Neriah, R. Levenson, and D. E. Housman. 1987. Ouabain resistance conferred by expression of the cDNA for a murine Na+, K+-ATPase alpha subunit. Science 237:901-903.
24. Kinsella, T. M., and G. P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
25. McCormack, J. E., D. Martineau, N. DePolo, S. Maifert, L. Akbarian, K. Townsend, W. Lee, M. Irwin, N. Sajjadi. D. J. Jolly, and J. Warner. 1997. Anti-vector immunoglobulin induced by retroviral vectors. Hum. Gene Ther. 8:1263-1273.
26. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
27. Murdoch, B., D. S. Pereira, X. Wu, J. E. Dick, and J. Ellis. 1997. A rapid screening procedure for the identification of high-liter retrovirus packaging clones. Gene Ther. 4:744-749.
28. Omer, C. A., K. Pogue-Geile, R. Guntaka, K. A. Staskus, and A. J. Faras. 1983. Involvement of directly repeated sequences in the generation of deletions of the avian sarcoma virus src gene. J. Virol. 47:380-382.
29. Onodera, M., A. Yachie, D. M. Nelson, H. Welchlin, R. A. Morgan, and R. M. Blaese. 1997. A simple and reliable method for screening retroviral producer clones without selectable markers. Hum. Gene Ther. 8:1189-1194.
30. Pathak, V. K., and H. M. Temin. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA 87:6024-6028.
31. Rhode, B. W., M. Emerman, and H. M. Temin. 1987. Instability of large direct repeats in retrovirus vectors. J. Virol. 61:925-927.
32. Richards, C. A., and B. E. Huber. 1993. Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Hum. Gene Ther. 4:143-150.
33. Riddell, S. R., M. Elliott, D. A. Lewinsohn, M. J. Gilbert, L. Wilson, S. A. Manley, S. D. Lupton, R. W. Overell, T. C. Reynolds, L. Corey, and P. D. Greenberg. 1996. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:216-223.
34. Sambrook, J., E. F. Fritsch, and T. Manlatis. 1969. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
36. Tikhonenko, A. T., and M. L. Linial. 1993. Transforming variants of the avian mwr-containing retrovirus FH3 arise prior to phenotypic selection. J. Virol. 67:3635-3638.
37. Yang, S., R. Delgado, S. R. King, C. Woffendin, C. S. Barker, Z. Y. Yang, L. Xu, G. P. Nolan, and G. J. Nabel. 1999. Generation of retroviral vector for clinical studies using transient transfection. Hum. Gene Ther. 10:123-132.